« Back
Home /
Fructose 6 Phosphate Kinase Antibody (N-term) Blocking peptide

Fructose 6 Phosphate Kinase Antibody (N-term) Blocking peptide

Item no.	ABC-BP8137a
Manufacturer	Abcepta
Amount	500 ug
Category	Neuroscience Targets for Rodent Neurosciences Peptides & Proteins Peptides
Type	Peptides
Format	Lyophilized
Specific against	other
Citations	Howard, T.D., et al., Genomics 34(1):122-127 (1996).Vasconcelos, O., et al., Proc. Natl. Acad. Sci. U.S.A. 92(22):10322-10326 (1995).Raben, N., et al., J. Biol. Chem. 268(7):4963-4967 (1993).Yamasaki, T., et al., Gene 104(2):277-282 (1991).Sharma, P.M., et al., J. Biol. Chem. 265(16):9006-9010 (1990).
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	ATP-dependent 6-phosphofructokinase,muscle type {ECO:0000255\|HAMAP-Rule:MF_03184},ATP-PFK {ECO:0000255\|HAMAP-Rule:MF_03184},PFK-M,27111 {ECO:0000255\|HAMAP-Rule:MF_03184},6-phosphofructokinase type A,Phosphofructo-1-kinase isozyme A,PFK-A,Phosphohexokinase {ECO:0000255\|HAMAP-Rule:MF_03184},PFKM,PFKX
Similar products	PFKM, PFKX, Phosphofructo-1-kinase isozyme A, PFK-A, ATP-dependent 6-phosphofructokinase, PFK-M, ATP-PFK {ECO:0000255\|HAMAP-Rule:MF_03184}, 27111 {ECO:0000255\|HAMAP-Rule:MF_03184}, Phosphohexokinase {ECO:0000255\|HAMAP-Rule:MF_03184}, muscle type {ECO:0000255\|HAMAP-Rule:MF_03184}, 6-phosphofructokinase type A
Available
Manufacturer - Category	Peptides; Blocking Peptides
Manufacturer - Targets	The synthetic peptide sequence used to generate the antibody AP8137a was selected from the N-term region of human PFKM. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Bio Background	Phosphofructokinase catalyzes the irreversible conversion of fructose 6 phosphate to fructose 1, 6 bisphosphate. Mammalian PFK is a complex isozyme consisting of 3 subunits: muscle (M), liver (L), and platelet (P). Only M type PFK isozyme is expressed in mature muscle, while erythrocytes contain both L and M subunits. Defects in PFKM are the cause of glycogen storage disease type 7 (GSD7), also known as Tarui disease.
Gene Name	PFKM
Subtitle	Synthetic peptide
Formulation	Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

ABC-BP8137a-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 500 ug

available

Delivery expected until 11/6/2025

Express Delivery: Save 14 days

Compare

Add to wishlist

Get an offer